Aditxt, Inc.
General ticker "ADTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $6.3M (TTM average)
Aditxt, Inc. does not follow the US Stock Market performance with the rate: -8.1%.
Estimated limits based on current volatility of 5.6%: low 2.61$, high 3.56$
Factors to consider:
- Total employees count: 47 as of 2023
- Top business risk factors: Operational and conduct risks, Product development risks, Labor/talent shortage/retention, IT security, Acquisition/divestiture risks
Short-term ADTX quotes
Long-term ADTX plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.93MM | $0.65MM | $0.13MM |
| Operating Expenses | $26.41MM | $26.71MM | $28.00MM |
| Operating Income | $-25.48MM | $-26.06MM | $-27.86MM |
| Non-Operating Income | $-2.17MM | $-6.33MM | $-7.16MM |
| Interest Expense | $0.75MM | $4.20MM | $7.36MM |
| R&D Expense | $7.27MM | $7.07MM | $10.89MM |
| Income(Loss) | $-27.65MM | $-32.39MM | $-35.02MM |
| Profit(Loss)* | $-27.65MM | $-32.38MM | $-34.45MM |
| Stockholders Equity | $5.21MM | $16.06MM | $8.87MM |
| Inventory | $0.95MM | $0.75MM | $0.01MM |
| Assets | $10.74MM | $44.58MM | $32.14MM |
| Operating Cash Flow | $-22.39MM | $-18.58MM | $-16.76MM |
| Capital expenditure | $0.37MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $-0.24MM | $-0.01MM | $-5.00MM |
| Financing Cash Flow | $17.53MM | $15.92MM | $22.50MM |
| Earnings Per Share** | $-27,650,000,000,000.00 | $-32,380,839,000,000.00 | $-3,062.41 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.